Atai stock forecast.

Atai stock closed up 30% at 19.45 on the stock market today, paring gains after surging more than 50% earlier. ... Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views;

Atai stock forecast. Things To Know About Atai stock forecast.

24. 3. 2023. ... ... predictions of future events. Although we believe that the ... Total stockholders' equity attributable to ATAI Life Sciences N.V. stockholders ...7 Wall Street research analysts have issued twelve-month price targets for Mind Medicine (MindMed)'s shares. Their MNMD share price targets range from $7.00 to $75.00. On average, they anticipate the company's share price to reach $25.43 in the next year. This suggests a possible upside of 684.8% from the stock's current price.Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.Stock Price Forecast. The 12 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 21.00, with a high estimate of 50.00 and a low estimate of 6.60. The median estimate represents a +650.00% increase from the last price of 2.80. Analyst Recommendations.

18. 6. 2021. ... Atai Life Sciences, a biotech company that uses psychedelics to treat ... Stock ScreenerNEW! Market Forecast · Options Investing; Subscribe; Sign ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ... Find real-time JTAI - Jet.AI Inc stock quotes, company profile, news and forecasts from CNN Business.

06:48 PM ET 11/23/2020. Atai Life Sciences, a company that backs Compass Pathways ( CMPS) and other psychedelic drug developers, said Monday that it had closed a $125 million funding round, the ...As such, ATAI has been trading -1490.91% off suggested target high and -286.36% from its likely low. ATAI Life Sciences N.V. (ATAI) estimates and forecasts. Looking at statistics comparing ATAI Life Sciences N.V. share performance against respective industry, we note that the company has outperformed competitors.

Get ATAI Life Sciences NV (ATAI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com15. 6. 2021. ... Since Atai Life Sciences is only going public, we don't have any forecast for the stock. Also, being a clinical-stage company, we don't have ...ATAI Life Sciences NV ATAI Morningstar Rating Unlock Stock XNAS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...

23 brokers have issued 1 year price targets for Advanced Micro Devices' shares. Their AMD share price targets range from $80.00 to $200.00. On average, they expect the company's share price to reach $134.77 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price.

Vice President-Strategic Operations. The latest Atari stock prices, stock quotes, news, and PONGF history to help you invest and trade smarter.

ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...Atai's stock is hurting, but its pipeline is still packed with promising programs. With its shares down by 60% in the last 12 months and a recent layoff …WebView atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ...Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Digital Turbine Inc have a median target of 5.50, with a high estimate of 12.00 and a low estimate of 5.00. The median ...30. 3. 2023. ... Psychedelic Stocks' Promising Outlook For Investors - Psychedelics Exclusive ... atai Founder Reveals 14 Reasons To Remain Optimistic - TDR ...Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.

2023 Outlook Reports. ... The small-cap market has been invaded by a flurry of psychedelics stocks to watch thanks to new company launches. ... ATAI Life Sciences is a clinical-stage biopharma ...ATAI Life Sciences N.V. Stock Chart and Share Price Forecast, Short-Term "ATAI" Stock Prediction for Next Days and Weeks Walletinvestor.com ATAI Life Sciences N.V. (ATAI) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Somalogic Inc have a median target of 4.75, with a high estimate of 7.00 and a low estimate of 2.30. The median estimate ...Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for ATAI stock stock is $13.5, which predicts an increase of 1,138.53%. The lowest target is $9.00 and the highest is $20. On average, analysts rate ATAI stock stock as a strong buy.May 25, 2023 · These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...

CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93.

Atari S.A. is an interactive entertainment company and an iconic gaming industry brand that transcends generations and audiences. The company is globally recognized for its multi-platform, interactive entertainment and licensed products.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.45. Based on our forecast, the price of ATAI will decline by -9.01% over the next 2 weeks and hit $0.95 by Thursday, December 14, 2023. In that time frame, ATAI 's share price is …WebAs of the end of March 2023, the ETF’s portfolio worth fell to $7.4 billion, as Cathie Wood started to sell stocks last year. According to a Bloomberg report, because of selling stocks at a loss ...Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...ATAI LIFE SCIENCES BV Share price. ATAI LIFE SCIENCES BV (ATAI) EUR0.10. Sell ... If the stock is listed overseas this figure will also include a Foreign Exchange ...Find the latest Atai Life Sciences N.V. (ATAI) stock quote, history, news and other vital information to help you with your stock trading and investing. RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.View the real-time ATAI price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, ...15. 6. 2021. ... Since Atai Life Sciences is only going public, we don't have any forecast for the stock. Also, being a clinical-stage company, we don't have ...

Market Cap. $464.54M. Enterprise Value -$9.65M. Total Cash (Recent Filing) $474.19M. Total Debt (Recent Filing) $0.00. Price to Earnings (P/E) -3.5. Beta 1.92. Next Earnings. Mar 26, 2024.

ATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ...

Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00 ...21. 6. 2023. ... Recent price, YTD Change, Market value (mil), Average price target, Implied ... ATAI Life Sciences / ATAI, 1.78, -31.2, 303.8, 12.30, 593. Caribou ...NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ...Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis. ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low.Find real-time NEE - Nextera Energy Inc stock quotes, company profile, news and forecasts from CNN Business.13. 1. 2023. ... atai Life Sciences Founder Christian Angermayer explains that all will ... Stock Market Sectors You Like 32:39 - 33:42 Optimism For Industry ...Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business. Next reporting date. February 26, 2024. EPS forecast (this quarter) $0.34. Annual revenue (last year) $960.5M. Annual profit (last year) $40.4M. Net profit margin.

3:24 pm. Articles. atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) August 10, 2023 Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients…. August 10, …Jul 28, 2022 · Atai Life Sciences. One of Atai Life Sciences' early investors was venture capitalist Peter Thiel. The company went public in June 2021 at $15 and is currently trading at $3.78 with a market cap ... 4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the company's stock price to reach $12.80 in the next twelve months. This suggests a possible upside of 1,063.6% from the stock's current price.Instagram:https://instagram. intl paper stockbest credit cards for high limitwhich broker is best for cryptocurrencyefav Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Aptinyx Inc APTX Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com. vanguard extended market etfuspy What is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Real Time Quote from BATS) $1.10 USD 0.00 (0.00%) Updated Nov 27, 2023 10:58 AM ET... should i buy target stock Find the latest COMPASS Pathways plc (CMPS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Stock analysis for ATAI Life Sciences NV (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.The company's stock is trading at about 20 cents per share as of Oct. 24. Cybin Inc . ( CYBN) Cybin, a Canadian psychedelic drug developer that produces treatments for depression, anxiety and ...